XNK’s patent portfolio is an important asset that represents a crucial obstacle for competitors to copy and commercialize the company’s technology.

A strong patent portfolio is also essential for future potential licenses and partnerships. The patents also enable XNK to maintain an edge over potential future competitors, while securing company value.

The XNK Therapeutics platformtechnology is currently protected by three patent families and the patent portfolio is under continuous development.